Stryker 

€321
616
-€0.8-0.25% Friday 13:38

统计数据

当日最高
321.2
当日最低
318.3
52周最高
-
52周最低
-
成交量
166
平均成交量
-
市值
137.35B
市盈率
40.18
股息收益率
0.91%
股息
2.92

即将到来

股息

0.91%股息收益率
10年增长
9.77%
5年增长
8.43%
3年增长
7.37%
1年增长
4.92%

收益

29Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
2
2.49
2.97
3.46
预期每股收益
2.77
实际每股收益
N/A

人们还关注

此列表基于关注SYK.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

380.13平均价格目标
最高估值为 €405。
来自过去6个月内的 16 个评级。这不是投资建议。
买入
75%
持有
25%
卖出
0%

关于

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Show more...
首席执行官
Mr. Kevin A. Lobo
员工
52000
国家
US
ISIN
US8636671013
WKN
000864952

上市公司